J.&J. Pauses Production of Its Covid Vaccine Despite Persistent Need
Johnson & Johnson’s easy-to-deliver Covid-19 shot is the vaccine of choice for much of the developing world. Yet the American company, which has already fallen far behind on its deliveries to poorer countries, late last year quietly shut down the only plant making usable batches of the vaccine, according to people familiar with the decision. […]Read More
J. & J. Booster Protects Against Severe Omicron, Study Says
A Johnson & Johnson booster shot provided strong protection against the Omicron variant, greatly reducing the risk of hospitalization, according to a clinical trial in South Africa. The study, which compared more than 69,000 boosted health care workers with a corresponding group of unvaccinated South Africans, found that two shots of the vaccine reduced the […]Read More
The C.D.C. recommends that other vaccines be preferred over J.&J.
The Centers for Disease Control and Prevention recommended on Thursday that Covid vaccines other than Johnson & Johnson’s should be preferred, after its advisers cited increasing evidence that the company’s shots can trigger a rare blood clotting disorder now linked to dozens of cases and at least nine deaths in the United States in the […]Read More